These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3493436)

  • 1. Positively darwinian molecules?
    Brown AL
    Nature; 1987 Mar 5-11; 326(6108):12-3. PubMed ID: 3493436
    [No Abstract]   [Full Text] [Related]  

  • 2. Accelerated evolution in the reactive centre regions of serine protease inhibitors.
    Hill RE; Hastie ND
    Nature; 1987 Mar 5-11; 326(6108):96-9. PubMed ID: 3493437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Conformational aspects of beta-trypsin interaction with substrates and pancreatic trypsin inhibitor. III. Catalytic act of trypsin and its inhibition].
    Popov EM; Godzhaev NM; Aliev RE
    Mol Biol (Mosk); 1986; 20(2):357-68. PubMed ID: 3702867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible evolutionary relationship between plant trypsin inhibitor, alpha-amylase inhibitor, and mammalian pancreatic secretory trypsin inhibitor (Kazal).
    Odani S; Koide T; Ono T
    J Biochem; 1983 Jun; 93(6):1701-4. PubMed ID: 6885745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation, characterization and cDNA sequencing of a Kazal family proteinase inhibitor from seminal plasma of turkey (Meleagris gallopavo).
    Słowińska M; Olczak M; Wojtczak M; Glogowski J; Jankowski J; Watorek W; Amarowicz R; Ciereszko A
    Comp Biochem Physiol B Biochem Mol Biol; 2008 Jun; 150(2):207-15. PubMed ID: 18430598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic engineering and the serpins.
    Boswell DR; Carrell RW
    Bioessays; 1988; 8(2):83-7. PubMed ID: 3282510
    [No Abstract]   [Full Text] [Related]  

  • 7. Differences in the evolution of seminal plasma acrosin inhibitors and pancreatic secretory trypsin inhibitors.
    Cechová D; Meloun B
    Hoppe Seylers Z Physiol Chem; 1979 Oct; 360(10):1497-500. PubMed ID: 500016
    [No Abstract]   [Full Text] [Related]  

  • 8. Positive darwinian selection in evolution of protein inhibitors of serine proteinases.
    Laskowski M; Kato I; Kohr WJ; Park SJ; Tashiro M; Whatley HE
    Cold Spring Harb Symp Quant Biol; 1987; 52():545-53. PubMed ID: 3502622
    [No Abstract]   [Full Text] [Related]  

  • 9. The serpins: evolution and adaptation in a family of protease inhibitors.
    Carrell RW; Pemberton PA; Boswell DR
    Cold Spring Harb Symp Quant Biol; 1987; 52():527-35. PubMed ID: 3502621
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction of Kazal-type inhibitor domains with serine proteinases: biochemical and structural studies.
    Schlott B; Wöhnert J; Icke C; Hartmann M; Ramachandran R; Gührs KH; Glusa E; Flemming J; Görlach M; Grosse F; Ohlenschläger O
    J Mol Biol; 2002 Apr; 318(2):533-46. PubMed ID: 12051857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein inhibitors of proteinases.
    Laskowski M; Kato I
    Annu Rev Biochem; 1980; 49():593-626. PubMed ID: 6996568
    [No Abstract]   [Full Text] [Related]  

  • 12. The molecular pathology of the serpins.
    Carrell RW; Aulak KS; Owen MC
    Mol Biol Med; 1989 Feb; 6(1):35-42. PubMed ID: 2666817
    [No Abstract]   [Full Text] [Related]  

  • 13. Pancreatic secretory trypsin inhibitor, cathodal trypsin, and pancreatic elastase in pancreatic juice collected at endoscopic retrograde cholangiopancreatography.
    Marks WH; Ohlsson K; Wehlin L; Russick C
    Curr Surg; 1985; 42(1):26-8. PubMed ID: 3844336
    [No Abstract]   [Full Text] [Related]  

  • 14. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
    Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
    Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structurally unique recombinant Kazal-type proteinase inhibitor retains activity when terminally extended and glycosylated.
    Kludkiewicz B; Kodrík D; Grzelak K; Nirmala X; Sehnal F
    Protein Expr Purif; 2005 Oct; 43(2):94-102. PubMed ID: 16095918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Kazal-type serine proteinase inhibitor from chicken liver (clTI-1): purification, primary structure, and inhibitory properties.
    Kubiak A; Jakimowicz P; Polanowski A
    Int J Biol Macromol; 2009 Aug; 45(2):194-9. PubMed ID: 19445959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma protease inhibitors in mouse and man: divergence within the reactive centre regions.
    Hill RE; Shaw PH; Boyd PA; Baumann H; Hastie ND
    Nature; 1984 Sep 13-19; 311(5982):175-7. PubMed ID: 6547997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compromise and accommodation in ecotin, a dimeric macromolecular inhibitor of serine proteases.
    Gillmor SA; Takeuchi T; Yang SQ; Craik CS; Fletterick RJ
    J Mol Biol; 2000 Jun; 299(4):993-1003. PubMed ID: 10843853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary nucleotide sequence for monitor peptide, a novel cholecystokinin-releasing peptide in the rat.
    Fukuoka SI; Scheele G
    Nucleic Acids Res; 1989 Dec; 17(23):10111. PubMed ID: 2602119
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional evolution within a protein superfamily.
    Yi Z; Vitek O; Qasim MA; Lu SM; Lu W; Ranjbar M; Li J; Laskowski MC; Bailey-Kellogg C; Laskowski M
    Proteins; 2006 May; 63(3):697-708. PubMed ID: 16463276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.